The Limited Times

Now you can see non-English news...

The Ministry of Health has approved a medicine for corona patients in a mild-moderate condition - Walla! news

2022-01-02T14:48:44.790Z


The antiviral drug Molnofiravir was approved by the FDA last week and is also expected to help those infected with the Omicron strain. It will be given in tablets to patients over 18 with at least one risk factor for deterioration in hospitalization or mortality. It will be taken for up to five days from the onset of the first symptoms


The Ministry of Health has approved a medicine for corona patients in a mild-moderate condition

The antiviral drug Molnofiravir was approved by the FDA last week and is also expected to help those infected with the Omicron strain.

It will be given in tablets to patients over 18 with at least one risk factor for deterioration in hospitalization or mortality.

It will be taken for up to five days from the onset of the first symptoms

Meirav Cohen

02/01/2022

Sunday, 02 January 2022, 16:10 Updated: 16:39

  • Share on Facebook

  • Share on WhatsApp

  • Share on Twitter

  • Share on Email

  • Share on general

  • Comments

    Comments

In the video: Bennett refers at the cabinet meeting to an increase in morbidity data in Corona (Photo: GPO)

The Ministry of Health today (Sunday) approved MSD's antiviral drug MSN to treat corona, according to the Corona virus' headquarters.

This is against the background of the sharp rise in coronary heart disease in Israel in light of the spread of the Omicron strain.



The Ministry of Health's approval came after the drug was approved last week in an emergency approval by the FDA, and it is expected to arrive in Israel in the coming days.

Its mechanism of action, designed to create errors in the genetic code of the virus and thus prevent its further replication, is not expected to be affected by the variant type of the corona virus, and is therefore also relevant in view of the spread of the omicron variant.

More on Walla!

Thousands of packets on the way: what's important to know about Pfizer's drug to Corona

To the full article

More on Walla!

  • The FDA has given emergency approval for Pfizer's pill against Corona

  • Reduce hospitalizations and mortality: A new drug for Corona gives hope to fight the virus

  • A smart test detects an increased risk of stroke - now in a special operation

Queue for corona tests outside the Ariella house in Tel Aviv, today (Photo: Reuven Castro)

Molnofiravir is an antiviral drug given in tablets.

The drug is intended to be given to corona patients with mild to moderate symptoms who have at least one risk factor for deterioration in hospitalization or mortality, when other existing and approved treatment alternatives in Israel are not suitable for them.



The drug, which is intended for people aged 18 and over, is given in pills and is intended for home treatment.

It should be given three to five days from the onset of symptoms.

The study found that the drug reduced hospitalizations and mortality by about 30% of the subjects, and its side effects observed in the study were moderate and similar between the treatment group and the placebo group.

  • news

  • Corona

Tags

  • Corona

  • Omicron variant

Source: walla

All news articles on 2022-01-02

You may like

Trends 24h

News/Politics 2024-03-27T16:45:54.081Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.